InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,264.40
(
-0.74%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
85.04
(
0.40%
)
Bitcoin
64,973.12
(
0.01%
)
Post# of 252271
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: ghmm post# 113543

Sunday, 01/30/2011 6:09:36 AM

Sunday, January 30, 2011 6:09:36 AM

Post# of 252271
I thought the PARP inhibitors class was the most promising new anti cancer therapy and that they could at least allow to reduce the doses of some chemotherapy agents in treating tumors with homologous recombination deficiency, such as BRCA1/2. There’s still hope that the the concept is correct in specific cancer mutated population.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up